Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Targeting midkine useful in multiple sclerosis model

March 14, 2008

New antipsychotic and anxiolytic agents described in recent patent literature

March 14, 2008

Avicena's HD-02 to enter NIH-sponsored phase III trial in HD

March 13, 2008

XenoPort presents positive phase I results with XP-21279

March 13, 2008

FDA accepts Pipex's IND application to conduct phase II clinical trial of oral flupirtine

March 13, 2008

Experiments clarify antidepressant activity of ketamine

March 13, 2008

Significant antimanic effects observed with tamoxifen in a randomized trial

March 13, 2008

Labopharm initiates phase III clinical trial of tramadol-acetaminophen combination drug

March 12, 2008

FDA Advisory Committee recommends approval of sugammadex

March 12, 2008

M's Science and Eisai enter agreement for sigma receptor agonist SA-4503

March 12, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...